Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.0001
0 %
$ 175
Market Cap
0.0
P/E
CASH FLOW STATEMENT
-11.5 M
OPERATING CASH FLOW
4.69 M
INVESTING CASH FLOW
656 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Clever Leaves Holdings Inc.
| Net Income | -19.8 M |
| Depreciation & Amortization | 2.85 M |
| Capital Expenditures | -31 K |
| Stock-Based Compensation | 818 K |
| Change in Working Capital | 135 K |
| Others | 3.56 M |
| Free Cash Flow | -11.5 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (19.8) | (66.2) | (45.7) | (36.7) | (46.0) | 7.4 |
| Depreciation & Amortization | 2.8 | 3.7 | 3.5 | 3.6 | 1.5 | 99 K |
| Deferred Income Tax | 0 | (6.7) | 0.9 | 5.7 | 6.2 | (0.2) |
| Stock Based Compensation | 0.8 | 2.3 | 11.5 | 1.7 | 1.5 | 0.2 |
| Other Operating Activities | 4.5 | 46.7 | 7.9 | 3.9 | 0.6 | (12.0) |
| Change in Working Capital | 0.1 | (9.0) | (14.3) | 37 K | (0.8) | 0.1 |
| Cash From Operations | (11.5) | (29.1) | (36.2) | (22.0) | (37.1) | (4.3) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | 31 K | (1.3) | (7.3) | (3.7) | (18.7) | (4.5) |
| Other Items | 4.7 | 2.5 | 0 | 0 | (15.2) | (3.8) |
| Cash From Investing Activities | 4.7 | 1.2 | (7.3) | (3.7) | (33.9) | (8.3) |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | (6.2) | 0 | 0 |
| Total Debt Repaid | (0.5) | (23.1) | 1.4 | 6.5 | 34.1 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.2) | (1.3) | 0.5 | 73.5 | 0.1 | 27.5 |
| Cash From Financing Activities | 0.7 | 3.3 | 1.8 | 91.8 | 62.8 | 27.5 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (6.0) | (24.8) | (41.8) | 66.3 | (8.1) | 15.1 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (11.5) | (30.4) | (43.5) | (25.6) | (55.7) | (8.7) |